NFE2L2 and non-small cell lung carcinoma: Beyond its traditional mechanism of targeting the VEGFR2/STAT3 signaling pathway, apatinib has been found to enhance ROS generation, suppress Nrf2 and p62 expression, and subsequently induce autophagy and apoptotic cell death in NSCLC 141.